Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Jim Cramer Discusses Eli Lilly (LLY) & Weight Loss Drugs
Jim Cramer highlighted Eli Lilly (LLY) and its strong performance in the weight loss drug market, noting its lead over Novo Nordisk. The company reported impressive Q4 and FY2025 earnings, leading to upgraded price targets from Freedom Capital and Deutsche Bank. Cramer specifically mentioned the success of Eli Lilly’s weight loss pill, which is gaining popularity due to its ease of use compared to injections.